Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) is projected to post its Q2 2025 quarterly earnings results before the market opens on Wednesday, August 13th. Analysts expect Monogram Orthopaedics to post earnings of ($0.11) per share for the quarter.
Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last released its quarterly earnings data on Wednesday, May 14th. The company reported ($0.10) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.02. On average, analysts expect Monogram Orthopaedics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Monogram Orthopaedics Stock Performance
Shares of MGRM traded down $0.04 during mid-day trading on Friday, hitting $5.40. 111,266 shares of the company traded hands, compared to its average volume of 969,170. The stock has a 50-day moving average price of $3.95 and a two-hundred day moving average price of $3.11. Monogram Orthopaedics has a 1 year low of $1.92 and a 1 year high of $6.02. The stock has a market cap of $192.73 million, a price-to-earnings ratio of -12.00 and a beta of 0.69.
Institutional Trading of Monogram Orthopaedics
A hedge fund recently raised its stake in Monogram Orthopaedics stock. Jane Street Group LLC raised its holdings in shares of Monogram Orthopaedics Inc. (NASDAQ:MGRM - Free Report) by 83.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,426 shares of the company's stock after buying an additional 8,810 shares during the period. Jane Street Group LLC owned about 0.06% of Monogram Orthopaedics worth $57,000 at the end of the most recent quarter. 0.45% of the stock is owned by institutional investors and hedge funds.
About Monogram Orthopaedics
(
Get Free Report)
Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
See Also
Before you consider Monogram Orthopaedics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monogram Orthopaedics wasn't on the list.
While Monogram Orthopaedics currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access